Pub. Date : 2019 Apr
PMID : 30985724
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Also, a higher percentage of patients on nilotinib therapy achieved EMR compared with patients on imatinib therapy (93.3% vs 63.6% on 3-month nilotinib therapy, P = .001; 88.9% vs 59.9% on 6-month nilotinib therapy, P = .004).This study demonstrates that EMR, especially a 3-month BCR-ABL <=1% and 6-month BCR-ABL <=0.1%, have predictive value for DMR achievement. | nilotinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |
| 2 | Also, a higher percentage of patients on nilotinib therapy achieved EMR compared with patients on imatinib therapy (93.3% vs 63.6% on 3-month nilotinib therapy, P = .001; 88.9% vs 59.9% on 6-month nilotinib therapy, P = .004).This study demonstrates that EMR, especially a 3-month BCR-ABL <=1% and 6-month BCR-ABL <=0.1%, have predictive value for DMR achievement. | nilotinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |